Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)💬 Info on mouse-over

63 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Adherens junction 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
2 Adherens junction 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
3 Alcoholism 💬
2件: DRD1, DRD2 💬 D00633 💬 Dopamine 3件:  6 ,  7 , 74 💬
4 Alcoholism 💬
2件: DRD1, DRD2 💬 D07870 💬 Dopamine 3件:  6 ,  7 , 74 💬
5 Alcoholism 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
6 Alcoholism 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
7 Alcoholism 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
8 Alcoholism 💬
1件: DRD2 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
9 Alcoholism 💬
1件: DRD2 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
10 Amphetamine addiction 💬
1件: DRD1 💬 D00633 💬 Dopamine 3件:  6 ,  7 , 74 💬
11 Amphetamine addiction 💬
1件: DRD1 💬 D07870 💬 Dopamine 3件:  6 ,  7 , 74 💬
12 Bladder cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
13 Bladder cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
14 Breast cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
15 Breast cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
16 Breast cancer 💬
2件: ESR1, ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
17 Breast cancer 💬
2件: ESR1, ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
18 Calcium signaling pathway 💬
2件: DRD1, DRD5 💬 D00633 💬 Dopamine 3件:  6 ,  7 , 74 💬
19 Calcium signaling pathway 💬
2件: DRD1, DRD5 💬 D07870 💬 Dopamine 3件:  6 ,  7 , 74 💬
20 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
21 Calcium signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
22 cAMP signaling pathway 💬
3件: DRD1, DRD2, DRD5 💬 D00633 💬 Dopamine 3件:  6 ,  7 , 74 💬
23 cAMP signaling pathway 💬
3件: DRD1, DRD2, DRD5 💬 D07870 💬 Dopamine 3件:  6 ,  7 , 74 💬
24 cAMP signaling pathway 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
25 cAMP signaling pathway 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
26 cAMP signaling pathway 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
27 cAMP signaling pathway 💬
1件: DRD2 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
28 cAMP signaling pathway 💬
1件: DRD2 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
29 cAMP signaling pathway 💬
3件: SSTR1, SSTR2, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
30 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
31 Central carbon metabolism in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
32 Choline metabolism in cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
33 Choline metabolism in cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
34 Cocaine addiction 💬
2件: DRD1, DRD2 💬 D00633 💬 Dopamine 3件:  6 ,  7 , 74 💬
35 Cocaine addiction 💬
2件: DRD1, DRD2 💬 D07870 💬 Dopamine 3件:  6 ,  7 , 74 💬
36 Cocaine addiction 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
37 Cocaine addiction 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
38 Cocaine addiction 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
39 Cocaine addiction 💬
1件: DRD2 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
40 Cocaine addiction 💬
1件: DRD2 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
41 Colorectal cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
42 Colorectal cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
43 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
44 Coronavirus disease - COVID-19 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
45 Cushing syndrome 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
46 Cushing syndrome 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
47 Cytokine-cytokine receptor interaction 💬
1件: GHR 💬 D02691 💬 Somatotropin 20件:  2 ,  3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬
48 Cytokine-cytokine receptor interaction 💬
1件: PRL 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
49 Cytokine-cytokine receptor interaction 💬
1件: PRL 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
50 Cytokine-cytokine receptor interaction 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
51 Dopaminergic synapse 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D00633 💬 Dopamine 3件:  6 ,  7 , 74 💬
52 Dopaminergic synapse 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D07870 💬 Dopamine 3件:  6 ,  7 , 74 💬
53 Dopaminergic synapse 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
54 Dopaminergic synapse 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
55 Dopaminergic synapse 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
56 Dopaminergic synapse 💬
3件: DRD2, DRD3, DRD4 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
57 Dopaminergic synapse 💬
3件: DRD2, DRD3, DRD4 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
58 EGFR tyrosine kinase inhibitor resistance 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
59 EGFR tyrosine kinase inhibitor resistance 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
60 Endocrine and other factor-regulated calcium reabsorption 💬
1件: ESR1 💬 D00962 💬 Clomifene 1件: 74 💬
61 Endocrine and other factor-regulated calcium reabsorption 💬
1件: ESR1 💬 D07726 💬 Clomifene 1件: 74 💬
62 Endocrine resistance 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
63 Endocrine resistance 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
64 Endocrine resistance 💬
2件: ESR1, ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
65 Endocrine resistance 💬
2件: ESR1, ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
66 Endocytosis 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
67 Endocytosis 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
68 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
69 Endometrial cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
70 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
71 Epithelial cell signaling in Helicobacter pylori infection 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
72 ErbB signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
73 ErbB signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
74 Estrogen signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
75 Estrogen signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
76 Estrogen signaling pathway 💬
2件: ESR1, ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
77 Estrogen signaling pathway 💬
2件: ESR1, ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
78 Focal adhesion 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
79 Focal adhesion 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
80 FoxO signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
81 FoxO signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
82 Gap junction 💬
2件: DRD1, DRD2 💬 D00633 💬 Dopamine 3件:  6 ,  7 , 74 💬
83 Gap junction 💬
2件: DRD1, DRD2 💬 D07870 💬 Dopamine 3件:  6 ,  7 , 74 💬
84 Gap junction 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
85 Gap junction 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
86 Gap junction 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
87 Gap junction 💬
1件: DRD2 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
88 Gap junction 💬
1件: DRD2 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
89 Gap junction 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
90 Gap junction 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
91 Gastric acid secretion 💬
1件: SSTR2 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
92 Gastric cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
93 Gastric cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
94 Glioma 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
95 Glioma 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
96 GnRH secretion 💬
1件: ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
97 GnRH secretion 💬
1件: ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
98 GnRH signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
99 GnRH signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
100 Growth hormone synthesis, secretion and action 💬
1件: GHR 💬 D02691 💬 Somatotropin 20件:  2 ,  3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬
101 Growth hormone synthesis, secretion and action 💬
4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
102 Hepatitis C 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
103 Hepatitis C 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
104 Hepatocellular carcinoma 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
105 Hepatocellular carcinoma 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
106 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
107 HIF-1 signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
108 Human cytomegalovirus infection 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
109 Human cytomegalovirus infection 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
110 Human papillomavirus infection 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
111 Human papillomavirus infection 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
112 JAK-STAT signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
113 JAK-STAT signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
114 JAK-STAT signaling pathway 💬
1件: GHR 💬 D02691 💬 Somatotropin 20件:  2 ,  3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬
115 JAK-STAT signaling pathway 💬
1件: PRL 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
116 JAK-STAT signaling pathway 💬
1件: PRL 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
117 JAK-STAT signaling pathway 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
118 MAPK signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
119 MAPK signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
120 Melanoma 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
121 Melanoma 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
122 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
123 MicroRNAs in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
124 Morphine addiction 💬
1件: DRD1 💬 D00633 💬 Dopamine 3件:  6 ,  7 , 74 💬
125 Morphine addiction 💬
1件: DRD1 💬 D07870 💬 Dopamine 3件:  6 ,  7 , 74 💬
126 Neuroactive ligand-receptor interaction 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D00633 💬 Dopamine 3件:  6 ,  7 , 74 💬
127 Neuroactive ligand-receptor interaction 💬
5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D07870 💬 Dopamine 3件:  6 ,  7 , 74 💬
128 Neuroactive ligand-receptor interaction 💬
3件: DRD2, DRD3, DRD4 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
129 Neuroactive ligand-receptor interaction 💬
3件: DRD2, DRD3, DRD4 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
130 Neuroactive ligand-receptor interaction 💬
2件: DRD2, PRL 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
131 Neuroactive ligand-receptor interaction 💬
2件: DRD2, PRL 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
132 Neuroactive ligand-receptor interaction 💬
2件: DRD2, PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
133 Neuroactive ligand-receptor interaction 💬
1件: GHR 💬 D02691 💬 Somatotropin 20件:  2 ,  3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬
134 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00292 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
135 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D00975 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
136 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01510 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
137 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01615 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
138 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01632 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
139 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D01948 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
140 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02174 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
141 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02591 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
142 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 D02592 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
143 Neuroactive ligand-receptor interaction 💬
4件: SSTR1, SSTR2, SSTR3, SSTR5 💬 D10147 💬 Pasireotide 3件: 67, 74, 75 💬
144 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
145 Non-small cell lung cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
146 Oxytocin signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
147 Oxytocin signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
148 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
149 Pancreatic cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
150 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
151 Parathyroid hormone synthesis, secretion and action 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
152 Parkinson disease 💬
2件: DRD1, DRD2 💬 D00633 💬 Dopamine 3件:  6 ,  7 , 74 💬
153 Parkinson disease 💬
2件: DRD1, DRD2 💬 D07870 💬 Dopamine 3件:  6 ,  7 , 74 💬
154 Parkinson disease 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
155 Parkinson disease 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
156 Parkinson disease 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
157 Parkinson disease 💬
1件: DRD2 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
158 Parkinson disease 💬
1件: DRD2 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
159 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
160 Pathways in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
161 Pathways in cancer 💬
2件: ESR1, ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
162 Pathways in cancer 💬
2件: ESR1, ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
163 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
164 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
165 Phospholipase D signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
166 Phospholipase D signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
167 PI3K-Akt signaling pathway 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
168 PI3K-Akt signaling pathway 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
169 PI3K-Akt signaling pathway 💬
1件: GHR 💬 D02691 💬 Somatotropin 20件:  2 ,  3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬
170 PI3K-Akt signaling pathway 💬
1件: PRL 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
171 PI3K-Akt signaling pathway 💬
1件: PRL 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
172 PI3K-Akt signaling pathway 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
173 Platinum drug resistance 💬
1件: ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
174 Platinum drug resistance 💬
1件: ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
175 Prolactin signaling pathway 💬
2件: ESR1, ESR2 💬 D00962 💬 Clomifene 1件: 74 💬
176 Prolactin signaling pathway 💬
2件: ESR1, ESR2 💬 D07726 💬 Clomifene 1件: 74 💬
177 Prolactin signaling pathway 💬
1件: PRL 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
178 Prolactin signaling pathway 💬
1件: PRL 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
179 Prolactin signaling pathway 💬
1件: PRL 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
180 Prostate cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
181 Prostate cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
182 Proteoglycans in cancer 💬
2件: EGFR, ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
183 Proteoglycans in cancer 💬
2件: EGFR, ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
184 Proteoglycans in cancer 💬
1件: ESR1 💬 D00962 💬 Clomifene 1件: 74 💬
185 Proteoglycans in cancer 💬
1件: ESR1 💬 D07726 💬 Clomifene 1件: 74 💬
186 Rap1 signaling pathway 💬
1件: DRD2 💬 D00780 💬 Bromocriptine 2件:  6 , 74 💬
187 Rap1 signaling pathway 💬
1件: DRD2 💬 D03165 💬 Bromocriptine 2件:  6 , 74 💬
188 Rap1 signaling pathway 💬
1件: DRD2 💬 D00987 💬 Cabergoline 3件:  6 , 74, 75 💬
189 Rap1 signaling pathway 💬
1件: DRD2 💬 D00633 💬 Dopamine 3件:  6 ,  7 , 74 💬
190 Rap1 signaling pathway 💬
1件: DRD2 💬 D07870 💬 Dopamine 3件:  6 ,  7 , 74 💬
191 Rap1 signaling pathway 💬
1件: DRD2 💬 D00784 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
192 Rap1 signaling pathway 💬
1件: DRD2 💬 D08489 💬 Ropinirole 4件:  2 ,  6 , 74, 309 💬
193 Rap1 signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
194 Rap1 signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
195 Ras signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
196 Ras signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
197 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
198 Regulation of actin cytoskeleton 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
199 Relaxin signaling pathway 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
200 Relaxin signaling pathway 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
201 Shigellosis 💬
1件: EGFR 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
202 Shigellosis 💬
1件: EGFR 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬
203 Thyroid hormone signaling pathway 💬
1件: ESR1 💬 D00962 💬 Clomifene 1件: 74 💬
204 Thyroid hormone signaling pathway 💬
1件: ESR1 💬 D07726 💬 Clomifene 1件: 74 💬
205 Tight junction 💬
1件: ERBB2 💬 D04024 💬 Lapatinib 3件: 34, 74, 75 💬
206 Tight junction 💬
1件: ERBB2 💬 D08108 💬 Lapatinib 3件: 34, 74, 75 💬